NEWS27 March 2018
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
NEWS27 March 2018
NORWAY and UK – Market research software company Confirmit and specialist healthcare consultancy 7i Group have joined forces to combine their market research and pharmaceutical knowledge for insight to improve patient outcomes.
The collaboration will create a better patient focused approach to drug development and the delivery of medicines, devices and treatment protocols.
7i will use Confirmit’s text analytics tool, Confirmit Genius, to listen to what patients and healthcare professionals (HCPs) are saying publicly about treatments. It will collate and analyse this unstructured data from sources such as patient forums and blogs to identify themes and sentiments.
All data is gathered in strict accordance with GDPR regulations (including informed consent) and market research codes of conduct.
Andrew Sellick, managing director at 7i Group, said: “Publicly sharing thoughts, opinions and experiences online is increasingly part of everyday life. It is often the environment in which patients and HCPs are most likely to express their views on a medicine or device in a ‘real world’ setting.”
0 Comments